Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18979182rdf:typepubmed:Citationlld:pubmed
pubmed-article:18979182lifeskim:mentionsumls-concept:C0150369lld:lifeskim
pubmed-article:18979182lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:18979182lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:18979182lifeskim:mentionsumls-concept:C0004153lld:lifeskim
pubmed-article:18979182lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:18979182lifeskim:mentionsumls-concept:C0684321lld:lifeskim
pubmed-article:18979182lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:18979182lifeskim:mentionsumls-concept:C0031082lld:lifeskim
pubmed-article:18979182lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:18979182pubmed:issue3lld:pubmed
pubmed-article:18979182pubmed:dateCreated2009-2-16lld:pubmed
pubmed-article:18979182pubmed:abstractTextWe investigated the ability of fluorodeoxyglucose positron emission tomography (FDG PET) imaging to serially monitor macrophage content in a rabbit model of atherosclerosis. Atherosclerosis was induced in rabbits (n = 8) by a combination of atherogenic diet and balloon denudation of the aorta. At the end of nine months, the rabbits were randomized to a further six months of the same atherogenic diet (progression group) or normal diet (regression group). In vivo uptake of FDG by the thoracic aorta was measured using aortic uptake-to-blood radioactivity ratios at the start and end of the randomized period. A significant increase in FDG uptake of the progression group after continued cholesterol feeding (aortic uptake-to-blood radioactivity: 0.57 +/- 0.02 to 0.68 +/- 0.02, P = 0.001), and a corresponding fall in FDG uptake of the regression group after returning to a normal chow diet (aortic uptake-to-blood radioactivity ratios: 0.67 +/- 0.02 to 0.53 +/- 0.02, P < 0.0001). FDG PET can quantify in vivo macrophage content and serially monitor changes in FDG activity in this rabbit model.lld:pubmed
pubmed-article:18979182pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18979182pubmed:languageenglld:pubmed
pubmed-article:18979182pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18979182pubmed:citationSubsetIMlld:pubmed
pubmed-article:18979182pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18979182pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18979182pubmed:statusMEDLINElld:pubmed
pubmed-article:18979182pubmed:monthMarlld:pubmed
pubmed-article:18979182pubmed:issn1875-8312lld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:BuchsbaumMont...lld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:MachacJosefJlld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:FusterValenti...lld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:BadimonJuan...lld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:WorthleySteph...lld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:HelftGérardGlld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:FayadZahi AZAlld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:ZamanAzfar...lld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:WorthleyMatth...lld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:TangCheukClld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:ZhangZhuang...lld:pubmed
pubmed-article:18979182pubmed:authorpubmed-author:LiewGary Y...lld:pubmed
pubmed-article:18979182pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18979182pubmed:volume25lld:pubmed
pubmed-article:18979182pubmed:ownerNLMlld:pubmed
pubmed-article:18979182pubmed:authorsCompleteYlld:pubmed
pubmed-article:18979182pubmed:pagination251-7lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:meshHeadingpubmed-meshheading:18979182...lld:pubmed
pubmed-article:18979182pubmed:year2009lld:pubmed
pubmed-article:18979182pubmed:articleTitleIn vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis.lld:pubmed
pubmed-article:18979182pubmed:affiliationZena and Michael A. Wiener Cardiovascular Institute, The Mount Sinai Medical Center, New York, NY 10029, USA. stephen.worthley@adelaide.edu.aulld:pubmed
pubmed-article:18979182pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18979182pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18979182lld:pubmed